UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 263

Sortiert nach

Impact of the Affordable Care Act on access to accredited facilities for cancer treatment

Health services research, 2024-05

2024

Volltextzugriff (PDF)

Clinical Trials in Urology: Predictors of Successes and Failures

The Journal of urology, 2020-10, Vol.204 (4), p.101097JU0000000000001072-810

2020

Volltextzugriff (PDF)

Small cell bladder cancer: should we consider prophylactic cranial irradiation?

International Brazilian journal of urology, 2019-03, Vol.45 (2), p.299-305

2019

Volltextzugriff (PDF)

Comparison of Primary Payer in Cancer Registry and Discharge Data

The American journal of managed care, 2023-09, Vol.29 (9), p.455-462

Kwon, Youngmin

2023

Volltextzugriff (PDF)

Effects of Medicaid managed care on early detection of cancer: Evidence from mandatory Medicaid managed care program in Pennsylvania

Health services research, 2024-07

2024

Volltextzugriff (PDF)

Association of Medicare eligibility with access to and affordability of care among older cancer survivors

Journal of cancer survivorship, 2024-03

2024

Volltextzugriff (PDF)

Patterns of multispecialty care for low- and intermediate-risk prostate cancer in the use of active surveillance

Urologic oncology, 2023-09, Vol.41 (9), p.388.e1-388.e8

2023

Volltextzugriff (PDF)

Diffusion and adoption of the surgical robot in urology

Translational andrology and urology, 2021-05, Vol.10 (5), p.2151-2157

2021

Volltextzugriff (PDF)

Extreme Price Variation for Generic Benign Prostatic Hyperplasia Medications

Urology (Ridgewood, N.J.), 2019-02, Vol.124, p.223-228

2019

Volltextzugriff (PDF)

Corrigendum to ‘The centralization of bladder cancer care and its implications for patient travel distance’ [Urologic Oncology: Seminars and Original Investigations volume 39 (2021) 834.e.9–834.e.20/9680]

Urologic oncology, 2022-05, Vol.40 (5), p.203-206

2022

Volltextzugriff (PDF)

Rate and Determinants of Completing Neoadjuvant Chemotherapy in Medicare Beneficiaries With Bladder Cancer: A SEER-Medicare Analysis

Urology (Ridgewood, N.J.), 2019-02, Vol.124, p.191-197

2019

Volltextzugriff (PDF)

Concentration of Opioid-Related Industry Payments in Opioid Crisis Areas

Journal of general internal medicine : JGIM, 2019-02, Vol.34 (2), p.187-189

2019

Volltextzugriff (PDF)

Characterising ‘bounce‐back’ readmissions after radical cystectomy

BJU international, 2019-12, Vol.124 (6), p.955-961

2019

Volltextzugriff (PDF)

The Shrinking Grey Zone of Postoperative Narcotics in the Midst of the Opioid Crisis: The No-opioid Urologist

European urology focus, 2020-11, Vol.6 (6), p.1168-1169

2020

Volltextzugriff (PDF)

Predictors of Delayed Intervention for Patients on Active Surveillance for Small Renal Masses: Does Renal Mass Biopsy Influence Our Decision?

Urology (Ridgewood, N.J.), 2016-12, Vol.98, p.88-96

2016

Volltextzugriff (PDF)

Trends and appropriateness of perioperative chemotherapy for muscle-invasive bladder cancer

Urologic oncology, 2019-07, Vol.37 (7), p.462-469

2019

Volltextzugriff (PDF)

Panniculectomy and Cystectomy: An Approach to the Morbidly Obese Patient

Case reports in urology, 2016-01, Vol.2016, p.6980843-4

2016

Volltextzugriff (PDF)

Comparison of Neoadjuvant and Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer

Clinical genitourinary cancer, 2020-06, Vol.18 (3), p.201-209.e2

2020

Volltextzugriff (PDF)

Changes in lower urinary tract symptoms after prostate brachytherapy

Journal of contemporary brachytherapy, 2011-09, Vol.3 (3), p.115-120

2011

Volltextzugriff (PDF)

Increasing use of positron emission tomography among medicare beneficiaries undergoing radical cystectomy

European journal of cancer care, 2020-07, Vol.29 (4), p.e13230-n/a

2020

Volltextzugriff (PDF)

Implications of Cystectomy Travel Distance for Hospital Readmission and Survival

Clinical genitourinary cancer, 2019-12, Vol.17 (6), p.e1171-e1180

2019

Volltextzugriff (PDF)

Preoperative Statin Use at the Time of Radical Prostatectomy Is Not Associated With Biochemical Recurrence or Pathologic Upgrading

Urology (Ridgewood, N.J.), 2016-11, Vol.97, p.153-159

2016

Volltextzugriff (PDF)

PD32-01 IMPACT OF ACCOUNTABLE CARE ORGANIZATIONS ON PROSTATE SPECIFIC ANTIGEN (PSA) TESTING AND PROSTATE BIOPSY

The Journal of urology, 2017-04, Vol.197 (4), p.e588-e588

2017

Volltextzugriff (PDF)

PD32-03 IMPACT OF MEDICARE SHARED SAVINGS PROGRAM ACCOUNTABLE CARE ORGANIZATIONS ON PROSTATE CANCER TREATMENT

The Journal of urology, 2017-04, Vol.197 (4), p.e589-e589

2017

Volltextzugriff (PDF)

PD32-12 UNDERSTANDING THE EFFECT OF THE HOSPITAL READMISSION REDUCTION PROGRAM ON SURGICAL READMISSIONS

The Journal of urology, 2017-04, Vol.197 (4), p.e592-e593

2017

Volltextzugriff (PDF)

1 – 25 von 263

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(233)
Mit Volltextzugriff
(197)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Impact of the Affordable Care Act on access to accredited facilities for cancer treatment

Clinical Trials in Urology: Predictors of Successes and Failures

Small cell bladder cancer: should we consider prophylactic cranial irradiation?

Comparison of Primary Payer in Cancer Registry and Discharge Data

Effects of Medicaid managed care on early detection of cancer: Evidence from mandatory Medicaid managed care program in Pennsylvania

Association of Medicare eligibility with access to and affordability of care among older cancer survivors

Patterns of multispecialty care for low- and intermediate-risk prostate cancer in the use of active surveillance

Diffusion and adoption of the surgical robot in urology

Extreme Price Variation for Generic Benign Prostatic Hyperplasia Medications

Corrigendum to ‘The centralization of bladder cancer care and its implications for patient travel distance’ [Urologic Oncology: Seminars and Original Investigations volume 39 (2021) 834.e.9–834.e.20/9680]

Rate and Determinants of Completing Neoadjuvant Chemotherapy in Medicare Beneficiaries With Bladder Cancer: A SEER-Medicare Analysis

Concentration of Opioid-Related Industry Payments in Opioid Crisis Areas

Characterising ‘bounce‐back’ readmissions after radical cystectomy

The Shrinking Grey Zone of Postoperative Narcotics in the Midst of the Opioid Crisis: The No-opioid Urologist

Predictors of Delayed Intervention for Patients on Active Surveillance for Small Renal Masses: Does Renal Mass Biopsy Influence Our Decision?

Trends and appropriateness of perioperative chemotherapy for muscle-invasive bladder cancer

Panniculectomy and Cystectomy: An Approach to the Morbidly Obese Patient

Comparison of Neoadjuvant and Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer

Changes in lower urinary tract symptoms after prostate brachytherapy

Increasing use of positron emission tomography among medicare beneficiaries undergoing radical cystectomy

Implications of Cystectomy Travel Distance for Hospital Readmission and Survival

Preoperative Statin Use at the Time of Radical Prostatectomy Is Not Associated With Biochemical Recurrence or Pathologic Upgrading

PD32-01 IMPACT OF ACCOUNTABLE CARE ORGANIZATIONS ON PROSTATE SPECIFIC ANTIGEN (PSA) TESTING AND PROSTATE BIOPSY

PD32-03 IMPACT OF MEDICARE SHARED SAVINGS PROGRAM ACCOUNTABLE CARE ORGANIZATIONS ON PROSTATE CANCER TREATMENT

PD32-12 UNDERSTANDING THE EFFECT OF THE HOSPITAL READMISSION REDUCTION PROGRAM ON SURGICAL READMISSIONS

Aktive Filter

Suchergebnisse filtern